US 11497781
Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor
granted A61KA61K35/761A61K39/3955
Quick answer
US patent 11497781 (Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor) held by CG ONCOLOGY, INC. expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CG ONCOLOGY, INC.
- Grant date
- Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K35/761, A61K39/3955, A61P, A61P35/02